GlassScriptPhysician profile
Russell G Beaty
NPI 1538188586
$23,591.05
in general payments reported to CMS, 2019-2025
57 companies · $4,948 in 2025
The $4,948 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,922 · 2020: $1,193 · 2021: $3,123 · 2022: $2,770 · 2023: $6,329 · 2024: $3,306 · 2025: $4,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $3,051 · Travel and Lodging: $1,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,053.79 |
| Education | $3,051.38 |
| Travel and Lodging | $1,478.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,676.38 | 2021-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $2,486.24 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $2,366.03 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Regeneron Healthcare Solutions, INC. | $1,865.78 | 2019-2025 | Dupixent |
| Genzyme Corporation | $1,057.00 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $981.64 | 2020-2025 | Acthar |
| Grifols USA, LLC | $956.89 | 2020-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $903.21 | 2019-2025 | Ofev, Jascayd |
| Harmony Biosciences LLC | $687.71 | 2020-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $606.58 | 2020-2025 | Glassia |
| Insmed, INC. | $523.49 | 2019-2025 | Arikayce |
| Amgen INC. | $508.63 | 2022-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $432.80 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $258.79 | 2019-2025 | Uptravi, Opsumit |
| Genentech USA, INC. | $256.46 | 2019-2024 | Xolair |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $248.02 | 2021 | |
| Axsome Therapeutics, INC. | $234.46 | 2023-2025 | Sunosi |
| Electromed, INC. | $212.62 | 2019-2025 | Smartvest |
| Viatris Specialty LLC | $204.39 | 2025 | Yupelri |
| Ethicon INC. | $167.51 | 2019-2025 | Monarch Platform |
| Philips North America LLC | $155.81 | 2019-2024 | (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $149.75 | 2019-2024 | Yupelri |
| Pfizer INC. | $147.15 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $139.21 | 2019-2024 | |
| Mallinckrodt Enterprises LLC | $130.17 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $127.85 | 2023-2025 | Lumryz |
| Gilead Sciences, INC. | $124.65 | 2021-2022 | |
| Abbvie INC. | $88.37 | 2021-2022 | |
| Eisai INC. | $76.23 | 2020-2022 | |
| United Therapeutics Corporation | $76.03 | 2023-2025 | Tyvaso, Tyvaso |
| Shire North American Group INC | $70.17 | 2019 | |
| Medtronic, INC. | $66.17 | 2022-2024 | Illumisite |
| Octapharma USA, INC. | $62.52 | 2021 | |
| Astellas Pharma US INC | $46.25 | 2021-2023 | Cresemba |
| Advanced Respiratory, INC | $39.78 | 2021 | |
| Ambu INC. | $34.88 | 2024 | |
| Boston Scientific Corporation | $33.99 | 2023-2024 | Spyglass Discover |
| Resmed Corp | $31.71 | 2025 | |
| Janssen Pharmaceuticals, INC | $29.43 | 2019-2020 | |
| Verona Pharma, INC. | $29.10 | 2025 | Ohtuvayre |
| Teva Pharmaceuticals USA, INC. | $28.93 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $27.07 | 2022-2023 | Quviviq |
| Merck Sharp & Dohme LLC | $22.34 | 2023 | |
| Lilly USA, LLC | $20.51 | 2025 | Zepbound |
| Vifor Pharma, INC. | $19.83 | 2024 | Zemaira |
| Nabriva Therapeutics, Plc | $19.64 | 2020 | |
| Csl Behring | $19.41 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.97 | 2022 | |
| Inogen, INC. | $17.11 | 2023 | Inogen At Home Stationary Concentrator |
| Paratek Pharmaceuticals, INC. | $15.73 | 2021 | |
| Olympus America INC. | $14.90 | 2021 | |
| Pulmonx Corporation | $14.23 | 2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Hikma Pharmaceuticals USA | $13.85 | 2023 | Ryaltris |
| Cook Medical LLC | $12.21 | 2019 | |
| Aytu Biopharma, INC. | $12.03 | 2020 | |
| Allergan, INC. | $12.00 | 2019 | |
| Veran Medical Technologies, INC. | $8.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Beaty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.